BITS Pilani Invites Pharmaceutical Chemistry Research Fellows

BITS Pilani Invites Pharmaceutical Chemistry Research Fellows

Applications are invited from suitable candidates for Junior Research Fellow (JRF) to work on the following project sponsored by the Department of Health Research (DHR), under the
supervision of Prof. Balaram Ghosh, Department of Pharmacy, BITS-Pilani, Hyderabad
Campus. Check out all the details on the same below:

Project Title: Development of Epigenome Targeted Therapeutics with Improved
Selectivity and Drug-ability for the Treatment of Cancer

Duration of the project: 3 years

Project position and number: JRF (1)

Fellowship amount: As per DHR/ICMR norms

Eligibility requirements: Candidates should be M. Pharm in Medicinal/Pharmaceutical
Chemistry and GPAT/NET/GATE qualified. Candidates with hands-on experience inmulti-step organic synthesis will be given preference.

How To Apply:

Interested candidates with the above mentioned qualification can send the detailed curriculum vitae (CV) along with the soft copy of published research papers if any, by 20.12.2021 (last date), to the Principal Investigator, Prof. Balaram Ghosh via email: Please note that only qualified and suitable candidates will be called for interview to be held at BITS-Pilani, Hyderabad Campus in the last week of December 2021 and no TA/DA will be paid for the interview. Selected candidates may be permitted to register for the Ph.D. program of BITS Pilani, Hyderabad Campus subject to the fulfillment of the requirements.

Dr. Balaram Ghosh, PhD
Associate Professor
Principal Investigator: Epigenetic Research Laboratory
Birla Institute of Technology and Science-Pilani Hyderabad Campus
Hyderabad, Telangana 500 078

Last Date To Apply: 20.12.2021

View Main Notification

Editors Note: BITS Pilani Invites Pharmaceutical Subscribe to Rasayanika for the latest chemistry and Pharma job openings, follow us on Facebook and Telegram and subscribe to our youtube channel for the latest updates on chemistry and Pharma jobs and much more.


Please enter your comment!
Please enter your name here